ALGN vs BVS · P/E 35, rev $2.10B vs rev $285.3M
Align Technology Inc (ALGN) versus Bioventus Inc (BVS) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Bioventus Inc (BVS) is a medical devices company listed on US.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported BVS revenue for 2026-06-27 was $285.3M. Net income was $36.6M. BVS currently screens at market cap $495.1M.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. BVS currently screens at market cap $495.1M.
Not investment advice. Open the ALGN and BVS stock pages for the full models.
Not investment advice.